Identifying and mitigating the biological effectors of the social determinants of health in cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40511610.
- Also identified by DOI 10.1093/jnci/djaf141 and PMC identifier 12505138.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recognizing the interconnectedness between social determinants of health (SDOH) and biological factors associated with cancer, the research community is working to identify and refine biological markers of SDOH that can help us better understand this complex interaction. The National Academies of Science, Engineering, and Medicine convened a workshop with the intent of exploring this interaction and how these factors affect cancer onset and cancer-related health outcomes.1 Workshop presentations and discussions provided an overview of biological effectors and SDOH; emerging research in these areas, including the development and validation of biomarkers and strategies to improve the evidence base for monitoring, diagnosing, policy, research, and clinical practice opportunities to improve health and address the impact of SDOH on cancer risk, diagnosis, and outcomes.
Medical subject headings
- Neoplasms
- Social Determinants of Health
- Biomarkers, Tumor